Literature DB >> 18222341

Natural history of primary IgA nephropathy.

François C Berthoux1, Hesham Mohey, Aïda Afiani.   

Abstract

Primary IgA nephropathy (IgAN) is the most frequent type of primary glomerulonephritis worldwide. The characteristic presentation is gross hematuria at the time of an infectious episode. A renal biopsy still is mandatory for the diagnosis. The natural history of the disease is characterized by clinical and pathologic progression over time, which can vary from a few years to more than 50 years. It is possible to make a broad prediction at the time of diagnosis of the long-term (20 years) risk of progressive chronic kidney disease, and then to end-stage renal disease requiring renal replacement therapy (20-year cumulative end-stage renal disease risk range, 14%-39%). The 3 major independent risk factors are arterial hypertension, proteinuria more than 1 g/d, and severe renal histopathologic lesions including hyalinosis, crescents, or defined by histopathologic scoring systems. When any clinical risk factors are present, patients should be targeted closely by appropriate treatments in the following order: (1) precise control of hypertension, (2) control of proteinuria when persisting for greater than 1 g/d, and (3) evidence-based treatment where available for severe lesions. This is a symptomatic treatment strategy because pathogenesis and etiology still remain unclear.

Entities:  

Mesh:

Year:  2008        PMID: 18222341     DOI: 10.1016/j.semnephrol.2007.10.001

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  52 in total

1.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

Review 2.  Secondary IgA nephropathy.

Authors:  Manish K Saha; Bruce A Julian; Jan Novak; Dana V Rizk
Journal:  Kidney Int       Date:  2018-05-24       Impact factor: 10.612

3.  Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients.

Authors:  Tibor Kovács; Tibor Vas; Csaba P Kövesdy; Péter Degrell; Györgyi Nagy; Zsuzsanna Rékási; István Wittmann; Judit Nagy
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

4.  Predicting the risk for dialysis or death in IgA nephropathy.

Authors:  François Berthoux; Hesham Mohey; Blandine Laurent; Christophe Mariat; Aida Afiani; Lise Thibaudin
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

Review 5.  Current Understanding of the Role of Complement in IgA Nephropathy.

Authors:  Nicolas Maillard; Robert J Wyatt; Bruce A Julian; Krzysztof Kiryluk; Ali Gharavi; Veronique Fremeaux-Bacchi; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2015-02-18       Impact factor: 10.121

6.  Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.

Authors:  Francois Berthoux; Hitoshi Suzuki; Hesham Mohey; Nicolas Maillard; Christophe Mariat; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

7.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

8.  The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases.

Authors:  Marie C Hogan; Heather N Reich; Peter J Nelson; Sharon G Adler; Daniel C Cattran; Gerald B Appel; Debbie S Gipson; Matthias Kretzler; Jonathan P Troost; John C Lieske
Journal:  Kidney Int       Date:  2016-08-12       Impact factor: 10.612

9.  Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

Authors:  Francois Berthoux; Hitoshi Suzuki; Lise Thibaudin; Hiroyuki Yanagawa; Nicolas Maillard; Christophe Mariat; Yasuhiko Tomino; Bruce A Julian; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

10.  Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.

Authors:  Perrine Jullien; Blandine Laurent; Guillaume Claisse; Ingrid Masson; Miriana Dinic; Damien Thibaudin; Francois Berthoux; Eric Alamartine; Christophe Mariat; Nicolas Maillard
Journal:  J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.